Search for: "Doe 35" Results 2241 - 2260 of 17,229
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2016, 7:10 am by Docket Navigator
But the fact that inventions here are implemented on computers or only exist in the computing realm does not save them. [read post]
3 Dec 2015, 6:43 am by Docket Navigator
Further, an assessment of the claims at issue — by a careful reading of the claims themselves — does not clearly reveal that the patents are abstract, that they have 'no particular concrete or tangible form,' which further prevents the Court from summarily finding the claims to be abstract prior to claim construction. [read post]
6 Nov 2017, 2:14 pm by Kenneth Vercammen Esq. Edison
A person convicted of or adjudicated delinquent for an offense under section 1 of P.L.1987, c.101 (C.2C:35-7), subsection b. of section 1 of P.L.1997, c.185 (C.2C:35-4.1), or any crime for which there exists a presumption of imprisonment pursuant to subsection d. of N.J.S.2C:44-1 or any other statute, or who has been previously convicted of an offense under subsection a. of N.J.S.2C:35-5 or a similar offense under any other law of this State, any other state or the United… [read post]
22 Mar 2024, 4:20 am by Dennis Crouch
This week USPTO Commissioner for Patents Vaishali Udupa issued a memorandum to all patent examiners entitled “Resources for Examining Means-Plus-Function and Step-Plus-Function Claim Limitations (35 U.S.C. 112(f)). [read post]
11 Jun 2013, 7:05 pm by Lawrence B. Ebert
§ 102, on „prima facie obviousness'under 35 U.S.C. [read post]
7 Aug 2019, 1:29 pm by Howard Knopf
The Supreme Court of Canada has specifically stated that this alone does not give rise to liability. [read post]
14 Jul 2014, 11:28 am
" Practice Tip #2: The FDA's ANDA process for generic drugs has been abbreviated such that, in general, the generic drug seeking approval does not require pre-clinical (animal and in vitro) testing. [read post]
19 Nov 2012, 8:57 am by Derek W. Jensen
Here is a list of the changes: Reduction of Estate Tax Exemption from $5.12 Million to $1.0 Million Increase in Maximum Estate Tax Rate from 35% to 55% Reduction of Gift Tax Exemption from $5.12 Million to $1.0 Million Increase in Maximum Gift Tax Rate from 35% to 55% Reduction of Generation Skipping Tax Exemption from $5.12 Million to $1.0 Million Increase in Generation Skipping Tax Rate from 35% to 55% Loss of Portability (ability to transfer unused exemption from… [read post]
27 Jul 2016, 2:15 pm
However, the court held that Petrella does require a change in Aukerman's rule that only pre-suit damages may be barred by laches. [read post]
27 Jul 2016, 2:15 pm
However, the court held that Petrella does require a change in Aukerman's rule that only pre-suit damages may be barred by laches. [read post]
10 Feb 2011, 8:58 am
  DEC does not require a life-cycle analysis to determine upstream impacts (i.e., impacts related to emissions caused prior to purchasing a remedial product), but DEC can request upstream emissions quantification if needed to support remedial decisions. [read post]